Russell Investments Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-42,976
| Closed | -$139K | – | 3143 |
|
|
2021
Q3 | $139K | Sell |
42,976
-6,198
| -13% | -$20K | ﹤0.01% | 2836 |
|
|
2021
Q2 | $206K | Sell |
49,174
-36,890
| -43% | -$155K | ﹤0.01% | 2901 |
|
|
2021
Q1 | $428K | Sell |
86,064
-35,742
| -29% | -$178K | ﹤0.01% | 2587 |
|
|
2020
Q4 | $1.54M | Sell |
121,806
-46,334
| -28% | -$585K | ﹤0.01% | 1895 |
|
|
2020
Q3 | $1.65M | Sell |
168,140
-3,323
| -2% | -$32.6K | ﹤0.01% | 1808 |
|
|
2020
Q2 | $1.7M | Buy |
171,463
+23,410
| +16% | +$232K | ﹤0.01% | 1736 |
|
|
2020
Q1 | $1.31M | Buy |
148,053
+68,172
| +85% | +$603K | ﹤0.01% | 1707 |
|
|
2019
Q4 | $736K | Sell |
79,881
-46,222
| -37% | -$426K | ﹤0.01% | 2255 |
|
|
2019
Q3 | $742K | Buy |
126,103
+109,928
| +680% | +$647K | ﹤0.01% | 2140 |
|
|
2019
Q2 | $194K | Buy |
+16,175
| New | +$194K | ﹤0.01% | 2522 |
|
|
2019
Q1 | – | Sell |
-94,650
| Closed | -$1.19M | – | 3049 |
|
|
2018
Q4 | $1.19M | Sell |
94,650
-22,849
| -19% | -$287K | ﹤0.01% | 1864 |
|
|
2018
Q3 | $1.75M | Buy |
117,499
+39,692
| +51% | +$591K | ﹤0.01% | 1822 |
|
|
2018
Q2 | $1.32M | Sell |
77,807
-86,911
| -53% | -$1.47M | ﹤0.01% | 1974 |
|
|
2018
Q1 | $3.77M | Buy |
164,718
+135,340
| +461% | +$3.1M | 0.01% | 1511 |
|
|
2017
Q4 | $760K | Buy |
+29,378
| New | +$760K | ﹤0.01% | 2273 |
|
|
2017
Q1 | – | Sell |
-42,704
| Closed | -$440K | – | 3111 |
|
|
2016
Q4 | $440K | Buy |
+42,704
| New | +$440K | ﹤0.01% | 2513 |
|